title: Dual hepatic metabolism of cerivastatin--clarifications.
authors.forename: J R
authors.initials: JR
authors.lastname: Guyton
authors.forename: C A
authors.initials: CA
authors.lastname: Dujovne
authors.forename: D R
authors.initials: DR
authors.lastname: Illingworth
mesh_terms: D000368:Aged; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D015248:Gemfibrozil / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics*; D006949:Hyperlipidemias / Q000188:drug therapy / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D011725:Pyridines / Q000009:adverse effects / Q000493:pharmacokinetics*; D012206:Rhabdomyolysis / Q000139:chemically induced / Q000378:metabolism; D013237:Stereoisomerism
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011725:Pyridines; C086276:cerivastatin; D015248:Gemfibrozil